Patent & Trade Mark


In recent years, FB Rice has increased its presence in Korea, working more closely with a network of Associates to advance our clients' interests in that country.

For further information on filing in Korea, please contact Sylvan Browne.

With specialist Korean Attorney skills in-house, language capabilities and an ever deepening understanding of the economic relationship between the two countries, we are seen by many foreign corporate clients as an ideal starting point for doing business in Korea.

The Republic of Korea became bound by the ‘Patent Cooperation Treaty’ (PCT) in August 1984.

Economic Overview

Australia and the Republic of Korea (ROK, also known as South Korea) are strong economic, political and strategic partners with common values and interests. People-to-people links between the two countries are increasing and make a significant contribution to the relationship.

Our important economic relationship continues to expand with the signature on 8 April 2014 of the Korea Australia Free Trade Agreement (KAFTA). The ROK is a key market for Australian minerals, energy and travel and education services and Australia is a major market for ROK passenger vehicles, petroleum, and electronic goods and parts. The investment relationship is also growing from a small base.

Bilateral Realtions

Bilateral relations have strengthened considerably in recent years. Cooperation on international affairs has reinforced the partnership. Australia and the ROK are active members of the G20, Asia-Pacific Economic Cooperation (APEC) and the East Asia Summit (EAS), and are both currently non-permanent members of the United Nations Security Council (UNSC).

Australia’s Joint Standing Committee on Treaties (JSCOT) has recommended the Government take binding treaty action on the Korea-Australia Free Trade Agreement (KAFTA) in a report tabled in Parliament. The report and the Government’s subsequent introduction in Parliament of customs and tariff legislation bring KAFTA closer to implementation.

South Korea is Australia’s third-largest export market and fourth-largest trading partner, with bilateral trade totalling A$32 billion in 2013. KAFTA is set to enhance Australia’s trading position with South Korea, where competitors such as the United States, the European Union and South-East Asian countries already benefit from preferential access. The agreement with South Korea also strengthens Australia’s position as a platform for expansion into Asia.

Sylvan Browne

Sylvan advises clients on developing patent strategies to suit their commercial objectives, with a specific focus on patent protection in the North American, European and Asian markets. In recent years, he has developed a particularly detailed understanding of the IP landscape in Korea and travels there regularly.

Sylvan previously worked with a prominent IP firm in Canada for four years, where he practiced as a patent agent representing clients before the Canadian Intellectual Property Office and the US Patent and Trademark Office. During his time practicing in North America, he gained significant experience drafting and prosecuting US, Canadian and European patents for sophisticated technology companies.

16 Sep 2017
At FB Rice, we recognise that diversity is a strength and that we are a better firm for having people with different ethnicity, sex, gender identity, sexual orientation and backgrounds.

06 Sep 2016
Monoclonal antibodies are important human therapeutic agents and represent some of the largest selling drugs in the world. Patents relating to antibodies are treated differently to some other compounds in some jurisdictions. This article touches on some of the important requirements for antibody patenting in some major Asian jurisdictions, namely Japan, China and South Korea.